Columvi (Glofitamab) : an Anti-CD20 & Anti-CD3 Bispecific T Cell Engager for diffuse large B-cell lymphoma (DLBCL)
CPE point : 1 per event
This is an in-service training for the staff of St Teresa’s Hospital & St Paul’s Hospital
Date:
2025-12-18
Time:
5:30-6:30pm
Venue:
Online
Organising Institute:
St Teresa’s Hospital & St Paul’s Hospital
Speaker:
Mr Bacon Ha, Master of Medical Sciences, Medical Affairs Partner Roche
Related CPE Activities:
